Kilter Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.26K Sell
10
-2
-17% -$1.12K ﹤0.01% 653
2026
Q1
$6.74K Hold
12
– – ﹤0.01% 533
2025
Q4
$8.12K Buy
12
+3
+33% +$2.04K ﹤0.01% 404
2025
Q3
$5.75K Buy
9
+2
+29% +$1.21K ﹤0.01% 431
2025
Q2
$3.75K Buy
+7
New +$3.35K ﹤0.01% 466

Other funds holding IDXX

Kilter Group's IDXX Position: Q2 2026 in Review

Kilter Group reduced its Idexx Laboratories (IDXX) stake by 17% in Q2 2026, selling an estimated $1.12K and leaving 10 shares worth $5.26K. The position accounts for ﹤0.01% of the portfolio, ranked #653.

Kilter Group first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.12K in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Kilter Group held 10 shares of Idexx Laboratories worth $5.26K as of Q2 2026.
  • Kilter Group sold 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
  • Idexx Laboratories made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #653 holding.
  • Kilter Group first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Kilter Group's Idexx Laboratories position peaked at $8.12K in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.